Avenue Therapeutics
Why Robinhood?
You can watch ATXI and buy or sell other stocks, ETFs, and their options commission-free!About ATXI
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain.
ATXI Key Statistics
Stock Snapshot
As of today, Avenue Therapeutics(ATXI) shares are valued at $2.73. The company's market cap stands at 61.49M.
On 2026-03-10, Avenue Therapeutics(ATXI) stock opened at —, reached a high of —, and a low of —.
The Avenue Therapeutics(ATXI)'s current trading volume is 0, compared to an average daily volume of 12.36M.
In the last year, Avenue Therapeutics(ATXI) shares hit a 52-week high of $1.85 and a 52-week low of $0.20.
In the last year, Avenue Therapeutics(ATXI) shares hit a 52-week high of $1.85 and a 52-week low of $0.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.